To include your compound in the COVID-19 Resource Center, submit it here.

Neon tops off $106M series B

Neoantigen play Neon Therapeutics Inc. (Cambridge, Mass.) raised $36 million in an extension

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE